Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

Equillium (Nasdaq: EQ) announced management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026 at 10:40am ET.

Rhea-AI Summary

Equillium (Nasdaq: EQ) announced management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026 at 10:40am ET.

Members of management will also be available for investor meetings with registered conference attendees.

Argus Feb 25 session

-4.69% close to close Open Argus

Details

News Market Reaction – EQ

On Feb 25, the day this news came out, EQ closed 4.69% below the previous close.

Data tracked by StockTitan Argus for the Feb 25 session.

Market Context

This announcement highlights Equillium’s continued investor outreach via a fireside chat at the Leer...

Analysis

This announcement highlights Equillium’s continued investor outreach via a fireside chat at the Leerink Partners Global Healthcare Conference on March 11, 2026 at 10:40am ET. It follows a series of recent conference appearances and financing-related updates, including a Q3 2025 report and a shelf registration for up to $250,000,000. Investors may monitor how management’s messaging evolves around pipeline plans, capital allocation, and use of the $75,000,000 ATM program.

Key Figures

Conference date: March 11, 2026 Conference time: 10:40am ET

Conference date

March 11, 2026

Leerink Partners 2026 Global Healthcare Conference fireside chat

Conference time

10:40am ET

Scheduled start time for Equillium fireside chat

Historical Context

5 past events · Latest: Feb 02

5 events

1. Feb 02

   Inducement grants

   24h Move

   +0.0%

   Inducement stock options for two new employees under 2024 Inducement Plan.

2. Nov 20

   Investor conferences

   24h Move

   +0.0%

   Planned participation in two early December 2025 healthcare investor conferences.

3. Nov 13

   Earnings and financing

   24h Move

   -9.1%

   Q3 2025 loss, revenue at $0, and private placement funding operations through 2027.

4. Nov 04

   Investor conferences

   24h Move

   -7.1%

   Announcements of Stifel presentation and Jefferies meetings with webcast access.

5. Nov 03

   Inducement grant

   24h Move

   +9.9%

   Stock option inducement grant to a new employee under 2024 Inducement Plan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LA JOLLA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026 at 10:40am ET.

Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference.

About Equillium
Equillium is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders. The company’s lead therapeutic candidate is EQ504, a potent and selective aryl hydrocarbon receptor (AhR) modulator designed with a multi-modal, non-immunosuppressive mechanism of action to be complementary to other inflammation and immunology agents. EQ504 is an investigational therapeutic program with potential for targeted, local delivery via enteric coating for the treatment of ulcerative colitis and other gastrointestinal diseases or inhaled formulations for the treatment of inflammatory lung diseases.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Equillium (EQ) present at the Leerink Partners 2026 Global Healthcare Conference?

Equillium will present on Wednesday, March 11, 2026 at 10:40am ET in a scheduled fireside chat. According to the company, management will deliver the session and be available for investor meetings during the conference.

What format will Equillium (EQ) use at the Leerink Partners 2026 conference?

Equillium will participate in a fireside chat format focused on company updates and strategy. According to the company, management will discuss recent developments and meet with registered investors attending the event.

Can investors meet Equillium (EQ) executives at the Leerink Partners 2026 conference?

Yes, Equillium management will be available for meetings with registered investors at the conference. According to the company, meetings are open to attendees who register through the conference organizers.

How can investors watch Equillium's (EQ) Leerink Partners 2026 fireside chat if not attending?

The press release does not announce a public webcast or replay of the fireside chat. According to the company, the session is scheduled on March 11, 2026, and investor access is tied to conference registration.

What topics will Equillium (EQ) likely cover in the March 11, 2026 Leerink fireside chat?

The company announced a fireside chat to discuss corporate updates and strategy rather than specific data releases. According to the company, management will present high-level developments and be available for investor Q&A at the conference.